The American journal of medicine · 2025
Decoding objective cough features in progressive pulmonary fibrosis: A 6-month feasibility study.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Feist Micheal D, Huang Yiming, Kalluri Meena, Cole Janis, Naikyar Esmatullah, Boulanger Pierre, Zanini Umberto, Birring Surinder, Ferrara Giovanni
Аннотация
OBJECTIVES: Cough is a significant medical problem in progressive pulmonary fibrosis. This study assessed the feasibility of utilizing an objective cough monitoring device over an extended duration and whether big data analytics could correlate with the Leicester Cough (LCQ) and King's Brief Interstitial Lung Disease (K-BILD) questionnaires.
METHODS: Patients with progressive pulmonary fibrosis were enrolled and followed throughout the six-month protocol. The primary outcome was for the participants to use the device for more than 70% of the days of the expected study duration. The secondary outcome involved an exploratory big data analysis, correlating the measurements from the device to the questionnaires scores.
RESULTS: Eight patients were enrolled in the study. Only one met the primary outcome. Nevertheless, the amount of data recorded during the study allowed for the correlation of cough intensity with the scores of LCQ and K-BILD. Cough count varied over time in all the patients, independently of the questionnaires.
CONCLUSION: For the first time, this study suggests that long-term digital cough data obtained directly from the patients through wearables may enable monitoring the course of diseases such as progressive pulmonary fibrosis.
METHODS: Patients with progressive pulmonary fibrosis were enrolled and followed throughout the six-month protocol. The primary outcome was for the participants to use the device for more than 70% of the days of the expected study duration. The secondary outcome involved an exploratory big data analysis, correlating the measurements from the device to the questionnaires scores.
RESULTS: Eight patients were enrolled in the study. Only one met the primary outcome. Nevertheless, the amount of data recorded during the study allowed for the correlation of cough intensity with the scores of LCQ and K-BILD. Cough count varied over time in all the patients, independently of the questionnaires.
CONCLUSION: For the first time, this study suggests that long-term digital cough data obtained directly from the patients through wearables may enable monitoring the course of diseases such as progressive pulmonary fibrosis.